| DJ-1 (PARK7) | |
|---|---|
| Gene | PARK7 |
| UniProt | Q99497 |
| PDB | 1P5F, 4ZGG, 1SOA |
| Mol. Weight | 20 kDa monomer (189 aa); ~40 kDa homodimer |
| Localization | Cytoplasm, nucleus, mitochondria |
| Family | DJ-1/ThiJ/PfpI superfamily |
| Chromosome | 1p36.23 |
| Diseases | Parkinson's Disease |
DJ-1, encoded by the PARK7 gene on chromosome 1p36.23, is a multifunctional 20 kDa protein that serves as a critical cellular sensor and protector against [oxidative stress[/mechanisms/oxidative-stress [1][2].
First identified as an oncogene in 1997, DJ-1 was linked to early-onset [Parkinson's Disease (PD)[/diseases/parkinsons in 2003 when Bonifati et al. discovered that homozygous loss-of-function mutations in PARK7 cause autosomal recessive
juvenile parkinsonism in Dutch and Italian families [1][3].
DJ-1 mutations account for approximately 1–2% of all autosomal recessive early-onset PD cases, making it the third most common cause after PRKN ([Parkin[/proteins/parkin and [PINK1[/proteins/pink1-protein
mutations [2][4].
DJ-1 is ubiquitously expressed but particularly enriched in the brain, with high levels in reactive [astrocytes[/cell-types/astrocytes and [dopaminergic neurons[/cell-types/dopaminergic-neurons of the [substantia
nigra[/cell-types/substantia-nigra — the very [neurons[/entities/neurons that degenerate in PD [2][5].
Its diverse functions as an oxidative stress sensor, transcriptional co-activator, molecular chaperone, and protein deglycase position it as a central node in neuroprotective signaling networks.
DJ-1 is a 189 amino acid protein whose crystal structure (PDB: 1P5F) reveals a compact α/β sandwich fold with seven β-strands and nine α-helices [1][2]:
The DJ-1 monomer adopts a flavodoxin-like fold belonging to the DJ-1/ThiJ/PfpI superfamily. This fold is shared with bacterial intracellular cysteine proteases (PfpI) and heat shock proteins (Hsp31), suggesting an evolutionary origin in stress response [1].
DJ-1 functions as an obligate homodimer in physiological conditions.
The dimer interface spans approximately 1,680 Ų and involves residues from helices α1, α7, and strands β3 and β4. [Dimerization is essential for all known DJ-1 functions — mutations that disrupt dimerization (most
notably L166P) are pathogenic [2][6].
DJ-1 contains three cysteine residues at positions 46, 53, and 106, of which Cys106 is the most functionally important [2][5][4]:
DJ-1 is a remarkably multifunctional protein whose activities collectively protect [neurons[/entities/neurons from oxidative damage [2][4][5]:
The oxidation-sensitive Cys106 residue allows DJ-1 to function as a cellular redox sensor.
Upon oxidative stress, Cys106 oxidation triggers conformational changes that activate DJ-1's protective functions, including translocation
to mitochondria and activation of antioxidant gene transcription [5][4].
DJ-1 stabilizes the antioxidant transcription factor Nrf2 by preventing its Keap1-mediated degradation, thereby upregulating expression of detoxifying enzymes including glutathione S-transferase, NAD(P)H quinone
oxidoreductase, and heme oxygenase-1 [2].
DJ-1 translocates to the outer mitochondrial membrane upon oxidative stress, where it maintains mitochondrial membrane potential, suppresses [reactive oxygen species (ROS)[/entities/ros production, and prevents mitochondrial
fragmentation [4][3].
It works in concert with the [PINK1[/proteins/pink1-protein/[Parkin[/proteins/parkin mitophagy pathway: while PINK1/Parkin clear severely damaged mitochondria, DJ-1 prevents moderate mitochondrial damage from
escalating to the point of requiring mitophagy.
DJ-1 functions as a redox-sensitive molecular chaperone that prevents aggregation of [alpha-synuclein[/proteins/alpha-synuclein and other aggregation-prone proteins. This activity is enhanced upon Cys106 oxidation, suggesting that oxidative stress activates DJ-1's chaperone function precisely when it is most needed [2][7].
DJ-1 catalyzes the deglycation of Maillard adducts — the harmful products formed by non-enzymatic reactions between sugars and proteins or nucleotides. This deglycase activity protects both proteins and DNA/RNA from glycation damage that accumulates during aging [4].
DJ-1 acts as a transcriptional co-activator for several neuroprotective genes by sequestering the transcriptional repressor PSF (polypyrimidine tract-binding protein-associated splicing factor), de-repressing tyrosine hydroxylase — the rate-limiting enzyme in [dopamine[/entities/dopamine biosynthesis [2].
In [microglia[/entities/microglia. Loss of DJ-1 leads to exaggerated microglial [neuroinflammation[/mechanisms/neuroinflammation, contributing to dopaminergic neuron death [8].
Homozygous or compound heterozygous loss-of-function mutations in PARK7 cause PARK7-type parkinsonism [1][3][4]:
DJ-1 loss-of-function leads to Parkinson's Disease through multiple convergent pathways [2][4][5]:
DJ-1 represents a promising therapeutic target and biomarker for Parkinson's Disease [2][4]:
The study of Park7 — Parkinsonism Associated Deglycase (Dj 1) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.